Nkarta (NKTX) EBITDA (2019 - 2026)

Nkarta's quarterly EBITDA came in at -$28.4 million in Q1 2026, up 11.36% year-on-year from -$25.5 million in Q1 2025, and down 3.02% quarter-over-quarter from -$27.5 million in Q4 2025.

Nkarta has reported EBITDA for 8 years, with the latest figure at -$28.4 million in Q1 2026.

  • For the quarter ending Q1 2026, EBITDA rose 11.36% year-over-year to -$28.4 million; the trailing twelve-month figure through Mar 2026 stood at -$100.7 million (up 8.84% YoY), and the FY2025 full-year result was -$104.4 million, up 3.49% from the prior year.
  • EBITDA for Q1 2026 stood at -$28.4 million, down from -$27.5 million in the prior quarter.
  • The five-year high for EBITDA was -$21.5 million in Q3 2025, with the low at -$33.7 million in Q2 2023.
  • Average EBITDA over 5 years is -$27.8 million, with a median of -$27.3 million recorded in 2023.
  • Year-over-year, EBITDA sank 39.27% in 2022 and grew 25.46% in 2024.
  • Tracing NKTX's EBITDA over 5 years: stood at -$31.9 million in 2022, then gained by 14.41% to -$27.3 million in 2023, then gained by 1.32% to -$27.0 million in 2024, then retreated by 2.09% to -$27.5 million in 2025, then decreased by 3.02% to -$28.4 million in 2026.
  • The last three EBITDA figures came in at -$28.4 million (Q1 2026), -$27.5 million (Q4 2025), and -$21.5 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -13.63 Mn
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -19.70 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -14.44 Mn
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 1.14 Bn
7 Evaxion A 62.56 Bn 62.54 Bn - -3.82 Mn
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 661.60 Mn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 201.19 Mn
10 Nkarta 232.80 Mn 232.80 Mn - -28.37 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -28.37 Mn
Dec 31, 2025 -27.54 Mn
Sep 30, 2025 -21.54 Mn
Jun 30, 2025 -23.27 Mn
Mar 31, 2025 -32.01 Mn
Dec 31, 2024 -26.98 Mn
Sep 30, 2024 -26.37 Mn
Jun 30, 2024 -25.13 Mn
Mar 31, 2024 -29.65 Mn
Dec 31, 2023 -27.34 Mn
Sep 30, 2023 -25.45 Mn
Jun 30, 2023 -33.71 Mn
Mar 31, 2023 -30.31 Mn
Dec 31, 2022 -31.94 Mn
Sep 30, 2022 -28.74 Mn
Jun 30, 2022 -27.25 Mn
Mar 31, 2022 -26.44 Mn
Dec 31, 2021 -22.93 Mn
Sep 30, 2021 -22.39 Mn
Jun 30, 2021 -21.56 Mn
Mar 31, 2021 -19.34 Mn
Dec 31, 2020 -17.90 Mn
Sep 30, 2020 -13.69 Mn
Jun 30, 2020 -51.06 Mn
Mar 31, 2020 -8.71 Mn
Dec 31, 2019 -10.49 Mn
Sep 30, 2019 -2.67 Mn
Jun 30, 2019 -4.84 Mn